Activation of deoxycytidine kinase by gamma-irradiation and inactivation by hyperosmotic shock in human lymphocytes. 2003

Zsolt Csapo, and Gergely Keszler, and Geza Safrany, and Tatjana Spasokoukotskaja, and Iannis Talianidis, and Maria Staub, and Maria Sasvari-Szekely
Institute of Medical Chemistry, Molecular Biology and Pathobiochemistry, Semmelweis University, P.O. Box 260, H-1444 Budapest, Hungary.

Deoxycytidine kinase (dCK) is a key enzyme in the intracellular metabolism of deoxynucleosides and their analogues, phosphorylating a wide range of drugs used in the chemotherapy of leukaemia and solid tumours. Previously, we found that activity of dCK can be enhanced by incubating primary cultures of lymphocytes with substrate analogues of the enzyme, as well as with various genotoxic agents. Here we present evidence that exposure of human lymphocytes to 0.5-2 Gy dosage of gamma-radiation as well as incubation of cells with calyculin A, a potent inhibitor of protein phosphatase 1 and 2A, both elevate dCK activity without changing the level of dCK protein. When cells were gamma-irradiated in the presence of calyculin A, a more pronounced activation of dCK was observed. In contrast, both basal and stimulated dCK activities were reduced by hyperosmotic treatment of the cells. DNA repair determined by the Comet assay and by thymidine incorporation was induced by irradiation. Complete repair of gamma-irradiated DNA was detected within 1 hr following the irradiation along with dCK activation, but the rate of repair was not accelerated by calyculin A. These data provide evidence for the activation of dCK upon DNA damage and repair that seems to be mediated by phosphorylation of the enzyme, suggesting the role of dCK in DNA repair processes.

UI MeSH Term Description Entries
D008214 Lymphocytes White blood cells formed in the body's lymphoid tissue. The nucleus is round or ovoid with coarse, irregularly clumped chromatin while the cytoplasm is typically pale blue with azurophilic (if any) granules. Most lymphocytes can be classified as either T or B (with subpopulations of each), or NATURAL KILLER CELLS. Lymphoid Cells,Cell, Lymphoid,Cells, Lymphoid,Lymphocyte,Lymphoid Cell
D008387 Marine Toxins Toxic or poisonous substances elaborated by marine flora or fauna. They include also specific, characterized poisons or toxins for which there is no more specific heading, like those from poisonous FISHES. Marine Biotoxins,Phycotoxins
D009994 Osmolar Concentration The concentration of osmotically active particles in solution expressed in terms of osmoles of solute per liter of solution. Osmolality is expressed in terms of osmoles of solute per kilogram of solvent. Ionic Strength,Osmolality,Osmolarity,Concentration, Osmolar,Concentrations, Osmolar,Ionic Strengths,Osmolalities,Osmolar Concentrations,Osmolarities,Strength, Ionic,Strengths, Ionic
D010080 Oxazoles Five-membered heterocyclic ring structures containing an oxygen in the 1-position and a nitrogen in the 3-position, in distinction from ISOXAZOLES where they are at the 1,2 positions. Oxazole,1,3-Oxazolium-5-Oxides,Munchnones,1,3 Oxazolium 5 Oxides
D011827 Radiation Emission or propagation of acoustic waves (SOUND), ELECTROMAGNETIC ENERGY waves (such as LIGHT; RADIO WAVES; GAMMA RAYS; or X-RAYS), or a stream of subatomic particles (such as ELECTRONS; NEUTRONS; PROTONS; or ALPHA PARTICLES). Radiations
D003842 Deoxycytidine Kinase An enzyme that catalyzes reversibly the phosphorylation of deoxycytidine with the formation of a nucleoside diphosphate and deoxycytidine monophosphate. Cytosine arabinoside can also act as an acceptor. All natural nucleoside triphosphates, except deoxycytidine triphosphate, can act as donors. The enzyme is induced by some viruses, particularly the herpes simplex virus (HERPESVIRUS HOMINIS). EC 2.7.1.74. Kinase, Deoxycytidine
D003853 Deoxyribonucleosides A purine or pyrimidine base bonded to DEOXYRIBOSE.
D004260 DNA Repair The removal of DNA LESIONS and/or restoration of intact DNA strands without BASE PAIR MISMATCHES, intrastrand or interstrand crosslinks, or discontinuities in the DNA sugar-phosphate backbones. DNA Damage Response
D004789 Enzyme Activation Conversion of an inactive form of an enzyme to one possessing metabolic activity. It includes 1, activation by ions (activators); 2, activation by cofactors (coenzymes); and 3, conversion of an enzyme precursor (proenzyme or zymogen) to an active enzyme. Activation, Enzyme,Activations, Enzyme,Enzyme Activations
D005720 Gamma Rays Penetrating, high-energy electromagnetic radiation emitted from atomic nuclei during NUCLEAR DECAY. The range of wavelengths of emitted radiation is between 0.1 - 100 pm which overlaps the shorter, more energetic hard X-RAYS wavelengths. The distinction between gamma rays and X-rays is based on their radiation source. Gamma Wave,Gamma Radiation,Nuclear X-Rays,Radiation, Gamma,X-Rays, Nuclear,Gamma Radiations,Gamma Ray,Gamma Waves,Nuclear X Rays,Nuclear X-Ray,Ray, Gamma,Wave, Gamma,Waves, Gamma,X Rays, Nuclear,X-Ray, Nuclear

Related Publications

Zsolt Csapo, and Gergely Keszler, and Geza Safrany, and Tatjana Spasokoukotskaja, and Iannis Talianidis, and Maria Staub, and Maria Sasvari-Szekely
February 2003, Biochemical pharmacology,
Zsolt Csapo, and Gergely Keszler, and Geza Safrany, and Tatjana Spasokoukotskaja, and Iannis Talianidis, and Maria Staub, and Maria Sasvari-Szekely
February 2003, Biochemical pharmacology,
Zsolt Csapo, and Gergely Keszler, and Geza Safrany, and Tatjana Spasokoukotskaja, and Iannis Talianidis, and Maria Staub, and Maria Sasvari-Szekely
January 2001, Biochemical pharmacology,
Zsolt Csapo, and Gergely Keszler, and Geza Safrany, and Tatjana Spasokoukotskaja, and Iannis Talianidis, and Maria Staub, and Maria Sasvari-Szekely
January 1998, Advances in experimental medicine and biology,
Zsolt Csapo, and Gergely Keszler, and Geza Safrany, and Tatjana Spasokoukotskaja, and Iannis Talianidis, and Maria Staub, and Maria Sasvari-Szekely
January 2006, Nucleosides, nucleotides & nucleic acids,
Zsolt Csapo, and Gergely Keszler, and Geza Safrany, and Tatjana Spasokoukotskaja, and Iannis Talianidis, and Maria Staub, and Maria Sasvari-Szekely
November 1998, Biochemical pharmacology,
Zsolt Csapo, and Gergely Keszler, and Geza Safrany, and Tatjana Spasokoukotskaja, and Iannis Talianidis, and Maria Staub, and Maria Sasvari-Szekely
October 1971, Experimental cell research,
Zsolt Csapo, and Gergely Keszler, and Geza Safrany, and Tatjana Spasokoukotskaja, and Iannis Talianidis, and Maria Staub, and Maria Sasvari-Szekely
February 1997, FEBS letters,
Zsolt Csapo, and Gergely Keszler, and Geza Safrany, and Tatjana Spasokoukotskaja, and Iannis Talianidis, and Maria Staub, and Maria Sasvari-Szekely
January 1998, Advances in experimental medicine and biology,
Zsolt Csapo, and Gergely Keszler, and Geza Safrany, and Tatjana Spasokoukotskaja, and Iannis Talianidis, and Maria Staub, and Maria Sasvari-Szekely
December 1998, The EMBO journal,
Copied contents to your clipboard!